The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 08, 2013
Filed:
Jul. 10, 2009
Kurt E. Brubaker, Eagle Point, OR (US);
Romulus K. Brazzell, Morrisville, NC (US);
Reza M. Haque, Randolph, NJ (US);
John C. Ice, Jr., Wake Forest, NC (US);
José L. Boyer, Chapel Hill, NC (US);
Joseph B. Boyd, Scottsdale, AZ (US);
Robert J. Dempsey, Middleton, MA (US);
Kurt E. Brubaker, Eagle Point, OR (US);
Romulus K. Brazzell, Morrisville, NC (US);
Reza M. Haque, Randolph, NJ (US);
John C. Ice, Jr., Wake Forest, NC (US);
José L. Boyer, Chapel Hill, NC (US);
Joseph B. Boyd, Scottsdale, AZ (US);
Robert J. Dempsey, Middleton, MA (US);
Inspire Pharmaceuticals, Inc., Whitehouse Station, NJ (US);
Abstract
The present invention relates to a method for treating non-infectious, inflammatory chronic posterior blepharitis in a subject. The present invention also relates to a method for treating chronic posterior blepharitis in a subject for over two weeks. The method comprises identifying a subject in need thereof, and topically administering to the eye of the subject a pharmaceutical formulation consisting essentially of an effective amount azithromycin. The present invention further relates to a method for treating dry eye secondary to blepharitis in a subject. The method comprises the steps of: identifying a subject suffering from dry eye secondary to posterior blepharitis, and topically administering to the eye of the subject a pharmaceutical formulation comprising an effective amount of azithromycin. The present invention further relates to method for reducing contact lens intolerance of a subject due to blepharitis or dry eye secondary to blepharitis.